Sponsored by
Beyond COVID-19: Life sciences reimagined
Every biopharma function has had to evaluate and adapt its roles and responsibilities almost overnight. So, how do we navigate the uncertain landscape ahead? We surveyed over 550 biopharma executives - from R&D to commercial – to gain practical insights on the current state and long-term outlook for the industry.
This new report (sponsored by EY) explores the findings of the biggest survey conducted in North America into pharma’s operations during the COVID-19 pandemic, analyzing the results with pharma leaders to help establish a framework for more patient-focused, sustainable care delivery, Today, Tomorrow and on The Road Ahead.
Download this free report now ->
Access this free 30+ page report and you will:
- See the impact of COVID-19 across the product lifecycle, highlighting commercial, HCP needs and pharma’s relationship with them, the marketing and the sales model, patient engagement, medical affairs and R&D
- Hear from pharma leaders who are plotting the industry’s re-mergence strategies into the “new normal”
- Benchmark your own response and experience to COVID-19 against hundreds of industry peers
Fill in your details now to get the full 30-page report and all the survey data ->
Plus additional commentary and analysis from Pharma’s shapeshifters, including:
Download this free report now ->
Best wishes,
Izzy
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.
Download this free 30+ page report now!
Fill in your details now to access the report, survey findings and critical analysis